NCT04249258View on ClinicalTrials.gov

Dobutamine on the Cardiac Conduction System

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

November 20, 2021

Study Completion Date

November 20, 2021

Conditions

Arrhythmias, Cardiac

Interventions

DRUG

Dobutamine

Dobutamine will then be administered at doses of 5mcg/kg/min, 10mcg/kg/min, 15mcg/kg/min and 20mcg/kg/min.

Trial Locations (1)

11040

Long Island Jewish Hospital, New Hyde Park

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

lead

Northwell Health

OTHER